Analyst consensus rating
Novartis Analyst Rating: Hold
NVS is rated Hold by 11 analysts with a $157.15 target. As of 2026-08-22.
Direct answer
Novartis's consensus rating is Hold.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $157.15.
Forecast evidence checked August 22, 2026.
Get free Novartis email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $158.86
- Average price target
- $157.15
- High price target
- $180.00
- Low price target
- $123.00
- Low target gap
- -22.6%
- Target upside
- -1.1%
- High target gap
- +13.3%
- Target range width
- 35.9%
- Consensus rating
- Hold
- Analysts
- 11
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Novartis?
Novartis has a verified Hold consensus. The same dataset has an average price target of $157.15.
How far are Novartis's low and high targets from the recorded price?
The low target implies -22.6%, while the high target implies +13.3%.
How many analysts are included in Novartis's consensus?
The verified consensus includes 11 analysts.
How is Novartis's target upside or downside calculated?
The average target of $157.15 is divided by the recorded price of $158.86, then one is subtracted to produce -1.1%. This does not guarantee a future return.
When was Novartis's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.